Clinic
Erie County Medical Center Corporation
Erie County Medical Center Corporation was paid $105.67M by Medicaid between Jan 2018 and Dec 2024, across 453 billing codes. Its largest line is 90791, psychiatric diagnostic evaluation — 15% of everything it billed.
33Billing provider infoERIE COUNTY MEDICAL CENTER CORPORATION
BUFFALO, NY 14215
BUFFALO, NY 14215
33aNPI1437197985assigned 06/04/2006
33bProvider typeEnd-Stage Renal Disease (ESRD) Treatment Clinic/Center
28Total paid$105.67M
24GClaims1,539,640
24DCodes billed453
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other End-Stage Renal Disease (ESRD) Treatment Clinic/Center providers in New York
Rank by total paid#1 of 231
Median peer was paid$774K
This provider vs. median137×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,977 | $449K | |
| 2019 | 98,900 | $6.27M | |
| 2020 | 271,109 | $17.41M | |
| 2021 | 325,633 | $18.97M | |
| 2022 | 301,081 | $27.94M | |
| 2023 | 304,577 | $19.36M | |
| 2024incomplete | 229,363 | $15.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 15% | 24,153 | 21,147 | $16.18M |
| G0378 | Hospital observation service, per hour | 8.7% | 7,767 | 3,282 | $9.19M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 8.7% | 86,746 | 73,270 | $9.14M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.2% | 28,774 | 25,976 | $5.54M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 4.6% | 37,598 | 23,142 | $4.83M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 4.4% | 49,649 | 32,331 | $4.62M |
| S9485 | Crisis intervention mental health services, per diem | 4.3% | 3,985 | 3,731 | $4.56M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.6% | 22,768 | 20,295 | $3.85M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.3% | 15,520 | 14,320 | $3.47M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.2% | 36,139 | 32,749 | $3.39M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.1% | 36,848 | 33,939 | $3.32M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.7% | 21,522 | 7,013 | $2.89M |
441 more codes
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2.7% | 37,751 | $2.87M |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 2.6% | 39,392 | $2.78M |
| 90999 | Dialysis (unlisted procedure) | 2.1% | 12,566 | $2.24M |
| 70450 | Computed tomography, head or brain; without contrast material | 1.5% | 7,338 | $1.59M |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.5% | 11,623 | $1.59M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 6,572 | $894K |
| 80053 | Comprehensive metabolic panel | <1% | 53,090 | $855K |
| G0390 | Trauma response team associated with hospital critical care service | <1% | 438 | $746K |
| 36415 | Collection of venous blood by venipuncture | <1% | 128,606 | $735K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 7,747 | $706K |
| H0001 | Alcohol and/or drug assessment | <1% | 4,608 | $702K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 23,327 | $675K |
| Q5105 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units | <1% | 12,454 | $590K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 841 | $554K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 5,186 | $472K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 19,670 | $470K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 6,838 | $453K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 2,226 | $430K |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 747 | $422K |
| 97116 | <1% | 2,843 | $402K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 2,102 | $387K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 3,078 | $365K |
| H2010 | Comprehensive medication services, per 15 minutes | <1% | 5,621 | $340K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 3,093 | $338K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 3,566 | $332K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 3,151 | $301K |
| 97161 | <1% | 2,964 | $289K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 4,003 | $281K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 10,575 | $263K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 16,098 | $220K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,433 | $212K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 16,047 | $207K |
| 12001 | <1% | 632 | $201K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 367 | $195K |
| D0120 | Dental checkup, returning patient | <1% | 4,738 | $192K |
| 70486 | <1% | 2,314 | $180K | |
| H0038 | Self-help/peer services, per 15 minutes | <1% | 3,670 | $176K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 3,764 | $171K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,880 | $170K |
| T1017 | Case management, billed per 15 minutes | <1% | 7,453 | $170K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 16,794 | $169K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,723 | $163K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 957 | $161K |
| 80061 | Lipid panel | <1% | 11,529 | $159K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 246 | $157K |
| 36416 | <1% | 9,247 | $156K | |
| 72131 | <1% | 1,664 | $149K | |
| HZ2ZZZZ | <1% | 321 | $148K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 7,448 | $145K |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | <1% | 2,542 | $144K |
| 20610 | <1% | 713 | $140K | |
| 72128 | <1% | 1,433 | $137K | |
| 64721 | <1% | 116 | $134K | |
| 88342 | <1% | 170 | $132K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 2,054 | $131K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,814 | $127K |
| 87902 | <1% | 660 | $126K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 52,613 | $125K |
| 76000 | <1% | 1,090 | $123K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 5,284 | $122K |
| D0140 | Limited oral evaluation - problem focused | <1% | 3,264 | $120K |
| 86480 | <1% | 2,122 | $118K | |
| 70498 | <1% | 694 | $118K | |
| 90715 | <1% | 4,439 | $115K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 19,232 | $114K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 14,856 | $113K |
| 83880 | <1% | 2,646 | $113K | |
| 73610 | <1% | 3,431 | $109K | |
| 82803 | <1% | 5,067 | $109K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 968 | $105K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 772 | $105K |
| D1110 | Prophylaxis - adult | <1% | 2,299 | $104K |
| 97162 | <1% | 1,096 | $103K | |
| 12002 | <1% | 333 | $100K | |
| 87536 | <1% | 2,028 | $100K | |
| 86850 | <1% | 4,569 | $98K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 5,502 | $96K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,233 | $94K |
| 71045 | Radiologic examination, chest; single view | <1% | 8,379 | $93K |
| 86900 | <1% | 4,945 | $93K | |
| 70487 | <1% | 373 | $92K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,608 | $86K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 7,517 | $84K |
| 86901 | <1% | 4,847 | $83K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 4,775 | $82K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 866 | $80K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 469 | $75K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 6,406 | $75K |
| 0002A | <1% | 2,119 | $74K | |
| 87799 | <1% | 516 | $72K | |
| 0001A | <1% | 2,275 | $72K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 402 | $71K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 251 | $71K |
| 93975 | <1% | 298 | $70K | |
| 97166 | <1% | 597 | $70K | |
| 90686 | <1% | 3,413 | $69K | |
| 87522 | Neg quan hep c or qual rna | <1% | 2,270 | $66K |
| 73630 | <1% | 3,039 | $61K | |
| 99406 | <1% | 2,558 | $60K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 9,902 | $58K |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | <1% | 394 | $55K |
| 87497 | <1% | 751 | $54K | |
| 83970 | <1% | 1,910 | $53K | |
| 92557 | <1% | 2,079 | $53K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,617 | $51K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 758 | $50K |
| H0050 | Alcohol and/or drug services, brief intervention, per 15 minutes | <1% | 1,680 | $49K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | <1% | 3,885 | $48K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 175 | $47K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,375 | $47K |
| H2011 | Crisis intervention service, per 15 minutes | <1% | 168 | $47K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 10,909 | $46K |
| 73562 | <1% | 645 | $45K | |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | <1% | 3,046 | $42K |
| D0330 | Panoramic radiographic image | <1% | 1,069 | $42K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 1,306 | $42K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 8,810 | $42K |
| 94060 | <1% | 1,137 | $41K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 367 | $41K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,536 | $41K |
| 80047 | <1% | 2,931 | $41K | |
| 84484 | <1% | 8,766 | $40K | |
| 96112 | <1% | 106 | $39K | |
| 94729 | <1% | 778 | $39K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 473 | $38K |
| 80069 | <1% | 3,500 | $35K | |
| 70491 | <1% | 324 | $35K | |
| 10060 | <1% | 185 | $34K | |
| 80197 | <1% | 1,945 | $34K | |
| 73502 | <1% | 1,577 | $34K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,452 | $34K |
| 97127 | <1% | 528 | $34K | |
| 86359 | <1% | 1,315 | $34K | |
| 73564 | <1% | 2,656 | $34K | |
| 93017 | <1% | 920 | $33K | |
| 74174 | <1% | 1,221 | $32K | |
| 83735 | <1% | 13,400 | $31K | |
| 81025 | <1% | 9,862 | $31K | |
| 85610 | <1% | 11,962 | $29K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 5,376 | $28K |
| G0008 | Administration of influenza virus vaccine | <1% | 2,246 | $28K |
| 90675 | <1% | 200 | $27K | |
| 97165 | <1% | 491 | $26K | |
| 82728 | <1% | 3,376 | $26K | |
| 87340 | <1% | 7,321 | $26K | |
| 82962 | <1% | 7,790 | $25K | |
| 0031A | <1% | 644 | $24K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 2,093 | $24K |
| 80074 | <1% | 1,457 | $23K | |
| 90837 | Psychotherapy session, about an hour | <1% | 661 | $23K |
| 81001 | <1% | 16,711 | $23K | |
| 73700 | <1% | 167 | $22K | |
| 86361 | <1% | 1,281 | $21K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,153 | $21K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 122 | $21K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 6,016 | $21K |
| 80076 | <1% | 1,755 | $20K | |
| 82570 | <1% | 5,978 | $20K | |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | <1% | 25 | $20K |
| 12011 | <1% | 76 | $19K | |
| 99408 | <1% | 536 | $19K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 380 | $18K |
| 84100 | <1% | 7,097 | $18K | |
| 86706 | <1% | 3,258 | $18K | |
| 71250 | <1% | 339 | $18K | |
| 0003A | <1% | 448 | $17K | |
| 84439 | <1% | 4,004 | $17K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 506 | $17K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 26 | $17K |
| 82607 | <1% | 3,046 | $17K | |
| 76770 | <1% | 126 | $16K | |
| 86780 | <1% | 4,046 | $15K | |
| 72110 | <1% | 1,335 | $15K | |
| 86803 | <1% | 7,519 | $15K | |
| 20680 | <1% | 13 | $15K | |
| 83550 | <1% | 3,725 | $14K | |
| 83615 | <1% | 2,789 | $14K | |
| 86704 | <1% | 5,087 | $14K | |
| 86141 | <1% | 3,959 | $14K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 212 | $14K |
| 86708 | <1% | 1,427 | $13K | |
| 0124A | <1% | 270 | $13K | |
| 90677 | <1% | 287 | $13K | |
| 86376 | <1% | 108 | $13K | |
| 82043 | <1% | 3,208 | $13K | |
| 73030 | <1% | 2,562 | $12K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 10,109 | $12K |
| Q3014 | Telehealth originating site facility fee | <1% | 809 | $12K |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 263 | $12K |
| 73200 | <1% | 97 | $12K | |
| 83540 | <1% | 3,707 | $11K | |
| 94726 | <1% | 579 | $11K | |
| 84702 | <1% | 3,783 | $11K | |
| 97130 | <1% | 166 | $11K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 185 | $11K |
| 84153 | <1% | 1,417 | $10K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 423 | $10K |
| 86039 | <1% | 231 | $10K | |
| 0054A | <1% | 273 | $10K | |
| 70496 | <1% | 55 | $10K | |
| 71271 | <1% | 195 | $9K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 39 | $9K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 109 | $9K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 128 | $9K |
| 99442 | <1% | 265 | $9K | |
| 85730 | <1% | 5,301 | $9K | |
| 62323 | <1% | 13 | $9K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 576 | $8K |
| 85014 | <1% | 4,962 | $8K | |
| 87088 | <1% | 930 | $8K | |
| 99091 | <1% | 168 | $8K | |
| 43235 | <1% | 12 | $8K | |
| 91300 | <1% | 1,879 | $8K | |
| 91200 | <1% | 783 | $8K | |
| 90670 | <1% | 260 | $8K | |
| 73130 | <1% | 3,012 | $8K | |
| 84156 | <1% | 2,919 | $7K | |
| 90732 | <1% | 124 | $7K | |
| 87631 | <1% | 183 | $7K | |
| 82746 | <1% | 1,491 | $7K | |
| 76536 | <1% | 244 | $7K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 49 | $7K |
| 0004A | <1% | 179 | $7K | |
| 96376 | <1% | 4,698 | $7K | |
| 84550 | <1% | 2,209 | $6K | |
| 97129 | <1% | 100 | $6K | |
| 73110 | <1% | 1,817 | $6K | |
| D0274 | Bitewings - four radiographic images | <1% | 218 | $6K |
| 88312 | <1% | 249 | $6K | |
| 82977 | <1% | 316 | $6K | |
| 88304 | <1% | 118 | $6K | |
| G0009 | Administration of pneumococcal vaccine | <1% | 458 | $6K |
| 0012A | <1% | 242 | $6K | |
| 0052A | <1% | 143 | $6K | |
| 82105 | <1% | 1,398 | $5K | |
| 94760 | <1% | 1,473 | $5K | |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | <1% | 28 | $5K |
| 82248 | <1% | 851 | $5K | |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | <1% | 66 | $5K |
| 90656 | <1% | 321 | $5K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 25 | $5K |
| 73590 | <1% | 2,017 | $5K | |
| 31579 | <1% | 14 | $4K | |
| 86235 | <1% | 744 | $4K | |
| 86481 | <1% | 219 | $4K | |
| 90651 | <1% | 111 | $4K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 172 | $4K |
| 76830 | Ultrasound, transvaginal | <1% | 152 | $4K |
| 84132 | <1% | 1,388 | $4K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 35 | $4K |
| 95819 | <1% | 91 | $4K | |
| 72170 | <1% | 1,004 | $4K | |
| 85651 | <1% | 4,184 | $4K | |
| 90734 | <1% | 206 | $4K | |
| 99495 | <1% | 99 | $3K | |
| 73080 | <1% | 1,177 | $3K | |
| 0011A | <1% | 242 | $3K | |
| 99221 | <1% | 138 | $3K | |
| 86769 | <1% | 146 | $3K | |
| 87517 | <1% | 92 | $3K | |
| 99496 | <1% | 57 | $3K | |
| 0051A | <1% | 73 | $3K | |
| 88112 | <1% | 54 | $3K | |
| 0064A | <1% | 66 | $3K | |
| 93990 | <1% | 60 | $2K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 28 | $2K |
| 87077 | <1% | 914 | $2K | |
| 83690 | <1% | 6,704 | $2K | |
| 94010 | <1% | 137 | $2K | |
| 87186 | <1% | 1,116 | $2K | |
| 86580 | <1% | 466 | $2K | |
| 90633 | <1% | 128 | $2K | |
| 90882 | <1% | 19 | $2K | |
| 85027 | <1% | 1,772 | $2K | |
| 73552 | <1% | 755 | $2K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 456 | $2K |
| 86762 | <1% | 382 | $2K | |
| 31575 | <1% | 39 | $2K | |
| 86765 | <1% | 410 | $2K | |
| 83605 | <1% | 5,108 | $2K | |
| 86160 | <1% | 183 | $2K | |
| 97760 | <1% | 42 | $1K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 28 | $1K |
| 90480 | <1% | 95 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 13 | $1K |
| 11721 | <1% | 50 | $1K | |
| 85007 | <1% | 1,514 | $1K | |
| 82150 | <1% | 1,767 | $1K | |
| 73090 | <1% | 1,181 | $1K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 9,745 | $1K |
| 73060 | <1% | 534 | $1K | |
| 72050 | <1% | 102 | $1K | |
| 86147 | <1% | 64 | $1K | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 570 | $1K |
| 86920 | <1% | 49 | $1K | |
| 73560 | <1% | 172 | $1K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 16 | $996.47 |
| 87040 | <1% | 1,129 | $959.16 | |
| 72100 | <1% | 114 | $918.60 | |
| C1769 | Guide wire | <1% | 120 | $902.41 |
| 73140 | <1% | 74 | $890.18 | |
| 86735 | <1% | 253 | $782.18 | |
| 86431 | <1% | 346 | $775.19 | |
| 96367 | <1% | 52 | $716.59 | |
| J2359 | Injection, olanzapine, 0.5 mg | <1% | 72 | $714.66 |
| 86832 | <1% | 18 | $710.10 | |
| 88307 | <1% | 13 | $703.20 | |
| 83883 | <1% | 180 | $683.09 | |
| 73523 | <1% | 37 | $664.59 | |
| 85379 | <1% | 857 | $656.96 | |
| 87071 | <1% | 950 | $656.07 | |
| 83010 | <1% | 194 | $650.47 | |
| 95886 | <1% | 48 | $638.38 | |
| 82550 | <1% | 995 | $633.12 | |
| 82172 | <1% | 155 | $623.79 | |
| 91322 | <1% | 59 | $608.37 | |
| 84520 | <1% | 2,080 | $599.95 | |
| 90746 | <1% | 15 | $562.75 | |
| 36430 | <1% | 12 | $545.30 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 205 | $509.35 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 4,848 | $495.52 |
| 84134 | <1% | 535 | $458.00 | |
| 99252 | <1% | 12 | $446.98 | |
| C9290 | Injection, bupivacaine liposome, 1 mg | <1% | 388 | $425.60 |
| 86830 | <1% | 31 | $391.19 | |
| 84481 | <1% | 43 | $386.29 | |
| 84460 | <1% | 436 | $376.84 | |
| 87147 | <1% | 414 | $375.84 | |
| 86833 | <1% | 18 | $366.02 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,382 | $336.31 |
| 87070 | <1% | 256 | $329.29 | |
| 86225 | <1% | 85 | $329.07 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,821 | $307.53 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 827 | $295.17 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 3,350 | $286.51 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 9,204 | $284.71 |
| 91301 | <1% | 200 | $279.84 | |
| 86256 | <1% | 54 | $268.20 | |
| 76775 | <1% | 12 | $252.00 | |
| 84480 | <1% | 54 | $248.68 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 352 | $241.37 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 6,292 | $215.87 |
| 87338 | <1% | 24 | $204.30 | |
| 82108 | <1% | 193 | $200.30 | |
| 82247 | <1% | 169 | $186.79 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 3,604 | $179.12 |
| 90710 | <1% | 12 | $175.70 | |
| 81003 | <1% | 922 | $172.68 | |
| 82784 | <1% | 15 | $169.35 | |
| 85018 | <1% | 1,478 | $165.47 | |
| 90698 | <1% | 13 | $160.65 | |
| 82310 | <1% | 302 | $154.67 | |
| 72052 | <1% | 14 | $151.50 | |
| 80320 | <1% | 998 | $150.90 | |
| 86696 | <1% | 50 | $150.15 | |
| J2704 | Injection, propofol, 10 mg | <1% | 3,475 | $149.32 |
| 90662 | <1% | 16 | $142.92 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 387 | $136.74 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,986 | $131.74 |
| S0166 | Injection, olanzapine, 2.5 mg | <1% | 392 | $129.91 |
| 84165 | <1% | 27 | $128.11 | |
| 97804 | <1% | 12 | $121.66 | |
| 73600 | <1% | 41 | $119.18 | |
| 85045 | <1% | 108 | $117.53 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 5,184 | $114.67 |
| 86787 | <1% | 37 | $105.02 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,880 | $101.83 |
| 84681 | <1% | 12 | $96.29 | |
| 86831 | <1% | 14 | $92.36 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 491 | $87.91 |
| 86200 | <1% | 39 | $84.72 | |
| 86828 | <1% | 14 | $82.96 | |
| 84466 | <1% | 13 | $77.21 | |
| 83921 | <1% | 25 | $74.65 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 28 | $73.20 |
| 84075 | <1% | 319 | $67.29 | |
| 70355 | <1% | 16 | $55.15 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 58 | $54.25 |
| 71101 | <1% | 49 | $52.00 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 832 | $51.10 |
| 82010 | <1% | 502 | $45.71 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 200 | $44.79 |
| 86258 | <1% | 13 | $42.06 | |
| 74018 | <1% | 40 | $41.52 | |
| 88313 | <1% | 12 | $39.92 | |
| 81002 | <1% | 51 | $38.24 | |
| 86644 | <1% | 12 | $32.65 | |
| 87808 | <1% | 1,195 | $30.31 | |
| 73620 | <1% | 16 | $30.30 | |
| 87450 | <1% | 42 | $28.67 | |
| 84450 | <1% | 27 | $27.75 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 67 | $23.50 |
| 86381 | <1% | 12 | $21.12 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 559 | $21.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 52 | $19.20 |
| 84560 | <1% | 27 | $17.82 | |
| 82565 | <1% | 32 | $16.68 | |
| 86592 | <1% | 13 | $16.35 | |
| 82542 | <1% | 25 | $14.69 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 14 | $12.78 |
| 84436 | <1% | 12 | $11.43 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | <1% | 68 | $10.60 |
| 82947 | <1% | 27 | $10.31 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 15 | $9.69 |
| 99454 | <1% | 14 | $7.11 | |
| 86695 | <1% | 12 | $5.76 | |
| S0028 | Injection, famotidine, 20 mg | <1% | 278 | $5.58 |
| 82270 | <1% | 12 | $5.30 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 90 | $4.40 |
| 82374 | <1% | 60 | $4.08 | |
| 87205 | <1% | 242 | $4.04 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 352 | $1.80 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 213 | $1.54 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 173 | $0.56 |
| 91305 | <1% | 221 | $0.01 | |
| 3288F | 0% | 1,911 | $0.00 | |
| 99080 | 0% | 3,615 | $0.00 | |
| 3078F | 0% | 582 | $0.00 | |
| 1160F | 0% | 941 | $0.00 | |
| 91312 | 0% | 121 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 38 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 128 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 87 | $0.00 |
| 99499 | 0% | 158 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 12 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 14 | $0.00 |
| 84295 | 0% | 13 | $0.00 | |
| J1953 | Injection, levetiracetam, 10 mg | 0% | 13 | $0.00 |
| 1101F | 0% | 1,377 | $0.00 | |
| 3074F | 0% | 1,306 | $0.00 | |
| 3079F | 0% | 203 | $0.00 | |
| 3044F | 0% | 32 | $0.00 | |
| J7999 | Compounded drug, not otherwise classified | 0% | 68 | $0.00 |
| 91303 | 0% | 133 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 73 | $0.00 |
| J3411 | Injection, thiamine hcl, 100 mg | 0% | 18 | $0.00 |
| 90375 | 0% | 12 | $0.00 | |
| 3008F | 0% | 14 | $0.00 | |
| G0010 | Administration of hepatitis b vaccine | 0% | 12 | $0.00 |
| 76377 | 0% | 12 | $0.00 | |
| 82435 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSWIATKOWSKI, JONATHAN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Erie County Medical Center Corporation | Buffalo, NY | $6.27M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.